These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 625308)

  • 21. Metabolic effects of the glucose tolerance factor (GTF) in normal and genetically diabetic mice.
    Tuman RW; Doisy RJ
    Diabetes; 1977 Sep; 26(9):820-6. PubMed ID: 892235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity of chronic dichloroacetate.
    Stacpoole PW; Moore GW; Kornhauser DM
    N Engl J Med; 1979 Feb; 300(7):372. PubMed ID: 215910
    [No Abstract]   [Full Text] [Related]  

  • 23. The metabolic effects of sodium dichloroacetate in experimental hepatitis in the rat [proceedings].
    Johnson GA; Alberti KG
    Biochem Soc Trans; 1977; 5(5):1387-9. PubMed ID: 923940
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulating mitochondrial metabolism by targeting pyruvate dehydrogenase with dichloroacetate, a metabolic messenger.
    Schoenmann N; Tannenbaum N; Hodgeman RM; Raju RP
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166769. PubMed ID: 37263447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyruvate dehydrogenase kinase regulates vascular inflammation in atherosclerosis and increases cardiovascular risk.
    Forteza MJ; Berg M; Edsfeldt A; Sun J; Baumgartner R; Kareinen I; Casagrande FB; Hedin U; Zhang S; Vuckovic I; Dzeja PP; Polyzos KA; Gisterå A; Trauelsen M; Schwartz TW; Dib L; Herrmann J; Monaco C; Matic L; Gonçalves I; Ketelhuth DFJ
    Cardiovasc Res; 2023 Jul; 119(7):1524-1536. PubMed ID: 36866436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cobalt-conjugated carbon quantum dots for in vivo monitoring of the pyruvate dehydrogenase kinase inhibitor drug dichloroacetic acid.
    Raut J; Islam MM; Sherpa RD; Sarkar B; Mandal SM; Hui SP; Mandal S; Sahoo P
    Sci Rep; 2022 Nov; 12(1):19366. PubMed ID: 36371411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATP8B1 Deficiency Results in Elevated Mitochondrial Phosphatidylethanolamine Levels and Increased Mitochondrial Oxidative Phosphorylation in Human Hepatoma Cells.
    Gómez-Mellado VE; Chang JC; Ho-Mok KS; Bernardino Morcillo C; Kersten RHJ; Oude Elferink RPJ; Verhoeven AJ; Paulusma CC
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dichloroacetate as a metabolic modulator of heart mitochondrial proteome under conditions of reduced oxygen utilization.
    Andelova N; Waczulikova I; Kunstek L; Talian I; Ravingerova T; Jasova M; Suty S; Ferko M
    Sci Rep; 2022 Sep; 12(1):16348. PubMed ID: 36175475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose Starvation or Pyruvate Dehydrogenase Activation Induce a Broad, ERK5-Mediated, Metabolic Remodeling Leading to Fatty Acid Oxidation.
    Khan AUH; Salehi H; Alexia C; Valdivielso JM; Bozic M; Lopez-Mejia IC; Fajas L; Gerbal-Chaloin S; Daujat-Chavanieu M; Gitenay D; Villalba M
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dichloroacetate, a pyruvate dehydrogenase kinase inhibitor, ameliorates type 2 diabetes via reduced gluconeogenesis.
    Katayama Y; Kawata Y; Moritoh Y; Watanabe M
    Heliyon; 2022 Feb; 8(2):e08889. PubMed ID: 35169648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein.
    Parkin ET; Hammond JE; Owens L; Hodges MD
    PLoS One; 2022; 17(1):e0255715. PubMed ID: 35025874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line.
    Klose K; Packeiser EM; Müller P; Granados-Soler JL; Schille JT; Goericke-Pesch S; Kietzmann M; Murua Escobar H; Nolte I
    PLoS One; 2021; 16(9):e0257403. PubMed ID: 34570803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Improves Host Control of
    van Doorn CLR; Schouten GK; van Veen S; Walburg KV; Esselink JJ; Heemskerk MT; Vrieling F; Ottenhoff THM
    Front Immunol; 2021; 12():739938. PubMed ID: 34552598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperpolarized NMR study of the impact of pyruvate dehydrogenase kinase inhibition on the pyruvate dehydrogenase and TCA flux in type 2 diabetic rat muscle.
    Park JM; Josan S; Hurd RE; Graham J; Havel PJ; Bendahan D; Mayer D; Chung Y; Spielman DM; Jue T
    Pflugers Arch; 2021 Nov; 473(11):1761-1773. PubMed ID: 34415396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of low-power laser therapy in improvement of the peripheral neuropathy induced by xenobiotics in rats.
    Mannaa FAE; Abdel-Wahhab KGE; Daoud EM; El Gendy AAR; Saber MM; Fadl NN
    Biochem Biophys Rep; 2021 Sep; 27():101085. PubMed ID: 34381880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of metabolic flexibility as a result of overexpression of pyruvate dehydrogenase kinases in muscle, liver and the immune system: Therapeutic targets in metabolic diseases.
    Jeon JH; Thoudam T; Choi EJ; Kim MJ; Harris RA; Lee IK
    J Diabetes Investig; 2021 Jan; 12(1):21-31. PubMed ID: 32628351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary Metabolites of The Endophytic Fungus
    Lee C; Li W; Bang S; Lee SJ; Kang NY; Kim S; Kim TI; Go Y; Shim SH
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31817301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The changing landscape of clinical trials for mitochondrial diseases: 2011 to present.
    Khayat D; Kurtz TL; Stacpoole PW
    Mitochondrion; 2020 Jan; 50():51-57. PubMed ID: 31669619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the hyaluronan matrix enhances metabolic anticancer therapy by dichloroacetate in vitro and in vivo.
    Twarock S; Reichert C; Bach K; Reiners O; Kretschmer I; Gorski DJ; Gorges K; Grandoch M; Fischer JW
    Br J Pharmacol; 2019 Dec; 176(23):4474-4490. PubMed ID: 31351004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of potent pyruvate dehydrogenase kinase inhibitors and evaluation of their anti-lung cancer activity under hypoxia.
    Yang R; Guo C
    Medchemcomm; 2018 Nov; 9(11):1843-1849. PubMed ID: 30568752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.